Record Information |
---|
Version | 5.0 |
---|
Status | Detected and Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2023-02-21 17:15:03 UTC |
---|
HMDB ID | HMDB0000678 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Isovalerylglycine |
---|
Description | Isovalerylglycine (IVG) is an acyl glycine. Acyl glycines are normally minor metabolites of fatty acids. However, the excretion of certain acyl glycines is increased in several inborn errors of metabolism. In certain cases the measurement of these metabolites in body fluids can be used to diagnose disorders associated with mitochondrial fatty acid beta-oxidation. Acyl glycines are produced through the action of glycine N-acyltransferase (EC 2.3.1.13) which is an enzyme that catalyzes the chemical reaction: acyl-CoA + glycine < -- > CoA + N-acylglycine. Isovalerylglycine is a byproduct of the catabolism of the aminoacid leucine. Accumulation of isovalerylglycine occurs in Isovaleric Acidemia (IVA). IVA (OMIM/ McKusick 243500) is an autosomal recessive disorder caused by mutations in the isovaleryl-CoA dehydrogenase (EC 1.3.99.10) gene. The deficiency of this enzyme in the metabolism of leucine leads to the accumulation of a series of isovaleryl-CoA metabolites, such as isovalerylglycine. It is very important to caution for false positive results when screening for isovaleric acidemia by tandem mass spectrometry based on dried blood-spot levels of C5-acylcarnitines, including isovalerylcarnitine and its isomer, pivaloylcarnitine; pivaloylcarnitine is derived from pivalate-generating antibiotics, and has caused many false-positive results (PMID: 17850781 ). Isovalerylglycine is a biomarker for the consumption of cheese. |
---|
Structure | [H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] InChI=1S/C7H13NO3/c1-5(2)3-6(9)8-4-7(10)11/h5H,3-4H2,1-2H3,(H,8,9)(H,10,11) |
---|
Synonyms | Value | Source |
---|
2-(3-Methylbutanoylamino)ethanoic acid | ChEBI | Isopentanoylglycine | ChEBI | N-Isopentanoylglycine | ChEBI | N-Isovaleroylglycine | ChEBI | 2-(3-Methylbutanoylamino)ethanoate | Generator | 3-Methylbutyrylglycine | HMDB | N-Isovaleryl-glycine | HMDB | [(3-Methylbutanoyl)amino]acetate | HMDB | [(3-Methylbutanoyl)amino]acetic acid | HMDB | N-Isovalerylglycine | HMDB | Isovalerylglycine | ChEBI |
|
---|
Chemical Formula | C7H13NO3 |
---|
Average Molecular Weight | 159.183 |
---|
Monoisotopic Molecular Weight | 159.089543287 |
---|
IUPAC Name | 2-(3-methylbutanamido)acetic acid |
---|
Traditional Name | isovalerylglycine |
---|
CAS Registry Number | 16284-60-9 |
---|
SMILES | [H]OC(=O)C([H])([H])N([H])C(=O)C([H])([H])C([H])(C([H])([H])[H])C([H])([H])[H] |
---|
InChI Identifier | InChI=1S/C7H13NO3/c1-5(2)3-6(9)8-4-7(10)11/h5H,3-4H2,1-2H3,(H,8,9)(H,10,11) |
---|
InChI Key | ZRQXMKMBBMNNQC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha amino acids. N-acyl-alpha amino acids are compounds containing an alpha amino acid which bears an acyl group at its terminal nitrogen atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | N-acyl-alpha amino acids |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha-amino acid
- Fatty amide
- N-acyl-amine
- Fatty acyl
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Carbonyl group
- Organonitrogen compound
- Organooxygen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | |
---|
Disposition | |
---|
Process | |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 87 - 90 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Isovalerylglycine,1TMS,isomer #1 | CC(C)CC(=O)NCC(=O)O[Si](C)(C)C | 1494.8 | Semi standard non polar | 33892256 | Isovalerylglycine,1TMS,isomer #2 | CC(C)CC(=O)N(CC(=O)O)[Si](C)(C)C | 1485.1 | Semi standard non polar | 33892256 | Isovalerylglycine,2TMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1522.6 | Semi standard non polar | 33892256 | Isovalerylglycine,2TMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1526.9 | Standard non polar | 33892256 | Isovalerylglycine,2TMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C)[Si](C)(C)C | 1624.4 | Standard polar | 33892256 | Isovalerylglycine,1TBDMS,isomer #1 | CC(C)CC(=O)NCC(=O)O[Si](C)(C)C(C)(C)C | 1728.4 | Semi standard non polar | 33892256 | Isovalerylglycine,1TBDMS,isomer #2 | CC(C)CC(=O)N(CC(=O)O)[Si](C)(C)C(C)(C)C | 1702.9 | Semi standard non polar | 33892256 | Isovalerylglycine,2TBDMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1967.6 | Semi standard non polar | 33892256 | Isovalerylglycine,2TBDMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1922.7 | Standard non polar | 33892256 | Isovalerylglycine,2TBDMS,isomer #1 | CC(C)CC(=O)N(CC(=O)O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1913.4 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0006-9200000000-30d4a8198b51e1741ecd | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (1 TMS) - 70eV, Positive | splash10-02mu-9400000000-7925a822e184ec8fe5b4 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Isovalerylglycine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-004r-9000000000-0a3d8ca5efe599736988 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-0a4i-9000000000-bdd258e50d1f36946722 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-052f-9000000000-c69489d7cef77e37b417 | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 20V, Negative-QTOF | splash10-00di-9000000000-f2a7577fbcf715ead09b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 40V, Negative-QTOF | splash10-00dl-9000000000-943f0aa07bdbc49fe1ae | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 20V, Negative-QTOF | splash10-00di-9000000000-fc6f913377a676ec6911 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 10V, Negative-QTOF | splash10-00di-9300000000-a8e4825232369d335cae | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 20V, Positive-QTOF | splash10-0a7i-9600000000-f88f3b21de99e67ddf29 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 40V, Positive-QTOF | splash10-0ufr-9000000000-40ef3cce661177a7fa76 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 10V, Positive-QTOF | splash10-06ur-8900000000-a7ebb3fa9615bc15486b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 35V, Positive-QTOF | splash10-0a4i-9000000000-1a36434c4052af0bcfe0 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 35V, Negative-QTOF | splash10-00di-9000000000-3af042b7e37d73c57609 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 10V, Negative-QTOF | splash10-00di-9100000000-a681e85779809020ebd1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Isovalerylglycine 40V, Negative-QTOF | splash10-00di-9000000000-eb0b00443a9121a49894 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 10V, Positive-QTOF | splash10-03di-7900000000-bdfe9288fa831ea12be2 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 20V, Positive-QTOF | splash10-0a6r-9100000000-a536e4ad32d713ca358a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 40V, Positive-QTOF | splash10-0a4i-9000000000-35336c548c7912945720 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 10V, Negative-QTOF | splash10-0a4i-1900000000-fad032ae217cd6458d13 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 20V, Negative-QTOF | splash10-0a4i-7900000000-3c2abe9b7592a2477edb | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 40V, Negative-QTOF | splash10-0ab9-9000000000-762e4bed2c894348be25 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 10V, Negative-QTOF | splash10-0ab9-9800000000-15fad814bd0853ccc685 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 20V, Negative-QTOF | splash10-00di-9000000000-e3d4167d339dc36d17cc | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 40V, Negative-QTOF | splash10-00di-9000000000-7b2fa1fa2126b1411d58 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 10V, Positive-QTOF | splash10-03dr-9400000000-11a34d1fd6d6b3c840c0 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Isovalerylglycine 20V, Positive-QTOF | splash10-0a73-9000000000-0668015853aa6666c93f | 2021-09-22 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 600 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | Not Available |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Detected and Quantified | 0.17 +/- 0.03 uM | Newborn (0-30 days old) | Both | Normal | | details | Blood | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.5925–7.1513 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 0.5424–5.6561 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 0.4771–4.7722 umol/mmol creatinine | Adult (25-30 years old) | Both | Not Available | | details | Urine | Detected and Quantified | 2-5 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 3.8 +/- 0.9 umol/mmol creatinine | Adolescent (13-18 years old) | Female | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (24-38years old) | Not Specified | Normal | | details | Urine | Detected and Quantified | 2.0 (0.4-4.0) umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.41 umol/mmol creatinine | Newborn (0-30 days old) | Both | Normal | | details | Urine | Detected and Quantified | 0.37 +/- 1.19 umol/mmol creatinine | Infant (0-1 year old) | Both | Normal | | details | Urine | Detected and Quantified | 2.322 +/- 1.914 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | 0.213-10.157 umol/mmol creatinine | Not Specified | Not Specified | Normal | | details | Urine | Detected and Quantified | <10 umol/mmol creatinine | Children (1 - 18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <1.15 umol/mmol creatinine | Adult (>18 years old) | Both | Normal | | details | Urine | Detected and Quantified | <14.205 umol/mmol creatinine | Children (1 - 13 years old) | Female | Normal | | details | Urine | Detected and Quantified | 0 - 4.5 umol/mmol creatinine | Adolescent (13-18 years old) | Both | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Detected and Quantified | 40.0 (1.3-80.0) uM | Newborn (0-30 days old) | Both | Isovaleric acidemia | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal cancer | | details | Urine | Detected and Quantified | 15-195 umol/mmol creatinine | Adolescent (13-18 years old) | Male | Isovaleric acidemia | | details | Urine | Detected and Quantified | 7.7 +/- 4.8 umol/mmol creatinine | Adolescent (13-18 years old) | Female | Anorexia nervosa | | details | Urine | Detected and Quantified | 2.813 +/- 2.181 umol/mmol creatinine | Children (1 - 13 years old) | Not Specified | Eosinophilic esophagitis | | details | Urine | Detected and Quantified | 0.0710-1.0654 umol/mmol creatinine | Infant (0-1 year old) | Not Specified | 2-Methylbutyryl-CoA dehydrogenase deficiency (SBACDD) | | details | Urine | Detected and Quantified | 4538.509 umol/mmol creatinine | Not Specified | Not Specified | Isovaleric acidemia | | details | Urine | Detected and Quantified | 0.6 umol/mmol creatinine | Adult (>18 years old) | Not Specified | Propionic acidemia | | details | Urine | Detected and Quantified | 4474.586 umol/mmol creatinine | Children (1 - 13 years old) | Female | Isovaleric acidemia | | details | Urine | Detected and Quantified | 3.4 - 36 umol/mmol creatinine | Adolescent (13-18 years old) | Both | Ethylmalonic encephalopathy | | details | Urine | Detected and Quantified | 511.381-795.482 umol/mmol creatinine | Newborn (0-30 days old) | Not Specified | Glutaric Aciduria II | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Isovaleric acidemia |
---|
- Shigematsu Y, Hata I, Tanaka Y: Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clin Chim Acta. 2007 Nov-Dec;386(1-2):82-6. Epub 2007 Aug 19. [PubMed:17850781 ]
- Krieger I, Tanaka K: Therapeutic effects of glycine in isovaleric acidemia. Pediatr Res. 1976 Jan;10(1):25-9. [PubMed:1246461 ]
- Matern D, He M, Berry SA, Rinaldo P, Whitley CB, Madsen PP, van Calcar SC, Lussky RC, Andresen BS, Wolff JA, Vockley J: Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics. 2003 Jul;112(1 Pt 1):74-8. [PubMed:12837870 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
- Yasutsugu Chinen, Sadao Nakamura, Kunihito Tamashiro, Osamu Sakamoto, Kyoko Tashiro, Takahiro Inokuchi, Koichi Nakanishi (2017). Isovaleric acidemia: Therapeutic response to supplementation with glycine, /react-text l react-text: 82 -carnitine, or both in combination and a 10-year. follow-up case study. Molecular Genetics and Metabolism Reports. Volume 11, June 2017, Pages 2-5. Molecular Genetics and Metabolism Reports.
| Colorectal cancer |
---|
- Sinha R, Ahn J, Sampson JN, Shi J, Yu G, Xiong X, Hayes RB, Goedert JJ: Fecal Microbiota, Fecal Metabolome, and Colorectal Cancer Interrelations. PLoS One. 2016 Mar 25;11(3):e0152126. doi: 10.1371/journal.pone.0152126. eCollection 2016. [PubMed:27015276 ]
- Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
| Anorexia nervosa |
---|
- Capo-chichi CD, Gueant JL, Lefebvre E, Bennani N, Lorentz E, Vidailhet C, Vidailhet M: Riboflavin and riboflavin-derived cofactors in adolescent girls with anorexia nervosa. Am J Clin Nutr. 1999 Apr;69(4):672-8. [PubMed:10197568 ]
| Eosinophilic esophagitis |
---|
- Slae, M., Huynh, H., Wishart, D.S. (2014). Analysis of 30 normal pediatric urine samples via NMR spectroscopy (unpublished work). NA.
| Propionic acidemia |
---|
- Riemersma M, Hazebroek MR, Helderman-van den Enden ATJM, Salomons GS, Ferdinandusse S, Brouwers MCGJ, van der Ploeg L, Heymans S, Glatz JFC, van den Wijngaard A, Krapels IPC, Bierau J, Brunner HG: Propionic acidemia as a cause of adult-onset dilated cardiomyopathy. Eur J Hum Genet. 2017 Nov;25(11):1195-1201. doi: 10.1038/ejhg.2017.127. Epub 2017 Aug 30. [PubMed:28853722 ]
| Ethylmalonic encephalopathy |
---|
- Lehnert W, Ruitenbeek W: Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome c oxidase deficiency. J Inherit Metab Dis. 1993;16(3):557-9. [PubMed:7609451 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Glutaric aciduria II |
---|
- Gregersen N, Kolvraa S, Rasmussen K, Christensen E, Brandt NJ, Ebbesen F, Hansen FH: Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II. J Inherit Metab Dis. 1980;3(3):67-72. [PubMed:6158623 ]
- G.Frauendienst-Egger, Friedrich K. Trefz (2017). MetaGene: Metabolic & Genetic Information Center (MIC: http://www.metagene.de). METAGENE consortium.
| Short/branched chain acyl-CoA dehydrogenase deficiency |
---|
- Matern D, He M, Berry SA, Rinaldo P, Whitley CB, Madsen PP, van Calcar SC, Lussky RC, Andresen BS, Wolff JA, Vockley J: Prospective diagnosis of 2-methylbutyryl-CoA dehydrogenase deficiency in the Hmong population by newborn screening using tandem mass spectrometry. Pediatrics. 2003 Jul;112(1 Pt 1):74-8. [PubMed:12837870 ]
|
|
---|
Associated OMIM IDs | - 243500 (Isovaleric acidemia)
- 114500 (Colorectal cancer)
- 606788 (Anorexia nervosa)
- 610247 (Eosinophilic esophagitis)
- 606054 (Propionic acidemia)
- 602473 (Ethylmalonic encephalopathy)
- 231680 (Glutaric aciduria II)
- 610006 (Short/branched chain acyl-CoA dehydrogenase deficiency)
|
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB022177 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 475516 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
METLIN ID | 5647 |
---|
PubChem Compound | 546304 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 70984 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | CE4968 |
---|
MarkerDB ID | MDB00000216 |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Bondi, S.; Eissler, F. Lipoproteins and the Fatty Degeneration of Cells. Biochemische Zeitschrift (1910), 23 499-513. |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Fries MH, Rinaldo P, Schmidt-Sommerfeld E, Jurecki E, Packman S: Isovaleric acidemia: response to a leucine load after three weeks of supplementation with glycine, L-carnitine, and combined glycine-carnitine therapy. J Pediatr. 1996 Sep;129(3):449-52. [PubMed:8804338 ]
- Goodman SI, McCabe ER, Fennessey PV, Mace JW: Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein. Pediatr Res. 1980 Jan;14(1):12-7. [PubMed:7360517 ]
- Hine DG, Hack AM, Goodman SI, Tanaka K: Stable isotope dilution analysis of isovalerylglycine in amniotic fluid and urine and its application for the prenatal diagnosis of isovaleric acidemia. Pediatr Res. 1986 Mar;20(3):222-6. [PubMed:3703611 ]
- Shigematsu Y, Hata I, Tanaka Y: Stable-isotope dilution measurement of isovalerylglycine by tandem mass spectrometry in newborn screening for isovaleric acidemia. Clin Chim Acta. 2007 Nov-Dec;386(1-2):82-6. Epub 2007 Aug 19. [PubMed:17850781 ]
|
---|